244 related articles for article (PubMed ID: 15812221)
1. Pure squamous cell carcinoma after intravesical BCG treatment. A case report.
Yurdakul T; Avunduk MC; Piskin MM
Urol Int; 2005; 74(3):283-5. PubMed ID: 15812221
[TBL] [Abstract][Full Text] [Related]
2. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
3. Intravesical Bacillus Calmette-Guerin for treating bladder cancer.
Boyd LA
Urol Nurs; 2003 Jun; 23(3):189-91, 199; quiz 192. PubMed ID: 12861735
[TBL] [Abstract][Full Text] [Related]
4. [Prospective study of the results at 2 years of one or two cycles of BCG endovesical instillations in the urothelial tumors of the bladder pT1 G3 after completed transurethral resection].
Rischmann P; Gamé X; Mazerolles C; Bittard H; Bouchot O; Descottes JL; Chopin D
Prog Urol; 2005 Dec; 15(6 Suppl 1):1266-70. PubMed ID: 16734216
[No Abstract] [Full Text] [Related]
5. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
6. [Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with endovesical BCG, for the prophylaxis of superficial bladder tumors].
Saint F; Irani J; Salomon L; Legrand P; Abbou CC; Chopin D
Prog Urol; 2001 Dec; 11(6):1242-50. PubMed ID: 11859659
[TBL] [Abstract][Full Text] [Related]
7. [Disseminated infection due to Mycobacterium bovis alter intravesical instillation of BCG].
de la Iglesia Fanjul I; de Castro Losa MR; Mourad F; Bajo Franco T
An Med Interna; 2007 Oct; 24(10):514-5. PubMed ID: 18333323
[No Abstract] [Full Text] [Related]
8. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2].
Wen R; Zhou G; Xie S; Lian B; Sun X; Chen J
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male.
Hillyer S; Gulmi FA
Can J Urol; 2009 Oct; 16(5):4866-9. PubMed ID: 19796470
[TBL] [Abstract][Full Text] [Related]
10. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
11. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
[TBL] [Abstract][Full Text] [Related]
12. BCG sepsis following inadvertent intravenous BCG administration for the treatment of bladder cancer can be effectively cured with anti-tuberculosis medications.
Akbulut Z; Canda AE; Atmaca AF; Cimen HI; Hasanoglu C; Balbay MD
N Z Med J; 2010 Nov; 123(1325):72-7. PubMed ID: 21317964
[TBL] [Abstract][Full Text] [Related]
13. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
Manasia P; Alcaraz A; Cetina A; Alcover J
J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420
[No Abstract] [Full Text] [Related]
14. [Rare, but significant complication after BCG instillation therapy after urothelial carcinoma].
Stahl T; Engelhardt F; Layer G
Rofo; 2013 Dec; 185(12):1199-200. PubMed ID: 23832635
[No Abstract] [Full Text] [Related]
15. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
Yates J; Stein B
Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
[TBL] [Abstract][Full Text] [Related]
16. [International Consensus Panel--treatment strategies for superficial bladder cancer].
Adler S; St Niclas M
Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
[No Abstract] [Full Text] [Related]
17. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.
Kaneko T; Fujita K; Homma Y
Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629
[TBL] [Abstract][Full Text] [Related]
18. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
19. Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma.
Leblanc B; Duclos AJ; Bénard F; Valiquette L; Paquin JM; Lapointe S; Mauffette F; Pharand D; Faucher R; Drouin G; Perreault JP
Can J Urol; 2000 Feb; 7(1):944-8. PubMed ID: 11121250
[TBL] [Abstract][Full Text] [Related]
20. Re: Agarwal a et al.: The safety and efficacy of different doses of bacillus Calmette Guerin in superficial bladder transitional cell carcinoma (Urology 2007;70:1075-1078).
Agrawal MS; Bansal S
Urology; 2009 Feb; 73(2):450-1. PubMed ID: 19185768
[No Abstract] [Full Text] [Related]
[Next] [New Search]